Literature DB >> 11173117

Too much of a good thing: mechanisms of gene action in Down syndrome.

R H Reeves1, L L Baxter, J T Richtsmeier.   

Abstract

The molecular mechanisms underlying the specific traits in individuals with Down syndrome (DS) have been postulated to derive either from nonspecific perturbation of balanced genetic programs, or from the simple, mendelian-like influence of a small subset of genes on chromosome 21. However, these models do not provide a comprehensive explanation for experimental or clinical observations of the effects of trisomy 21. DS is best viewed as a complex genetic disorder, where the specific phenotypic manifestations in a given individual are products of genetic, environmental and stochastic influences. Mouse models that recapitulate both the genetic basis for and the phenotypic consequences of trisomy provide an experimental system to define these contributions.

Entities:  

Mesh:

Year:  2001        PMID: 11173117     DOI: 10.1016/s0168-9525(00)02172-7

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  42 in total

1.  2001 William Allan Award Address. From Down syndrome to the "human" in "human genetics".

Authors:  Charles J Epstein
Journal:  Am J Hum Genet       Date:  2001-12-26       Impact factor: 11.025

2.  The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: implications for mental retardation.

Authors:  Karen T Chang; Yi-Jun Shi; Kyung-Tai Min
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

3.  Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.

Authors:  Robert Lyle; Corinne Gehrig; Charlotte Neergaard-Henrichsen; Samuel Deutsch; Stylianos E Antonarakis
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

4.  Down syndrome and postoperative complications after paediatric cardiac surgery: a propensity-matched analysis.

Authors:  Roland Tóth; Péter Szántó; Zsolt Prodán; Daniel J Lex; Erzsébet Sápi; András Szatmári; János Gál; Tamás Szántó; Andrea Székely
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-05

5.  Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome.

Authors:  Karen T Chang; Kyung-Tai Min
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-21       Impact factor: 11.205

Review 6.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

7.  Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells.

Authors:  Erin L McMillan; Allison L Kamps; Samuel S Lake; Clive N Svendsen; Anita Bhattacharyya
Journal:  Am J Stem Cells       Date:  2012-06-03

8.  The Influence of trisomy 21 on facial form and variability.

Authors:  John M Starbuck; Theodore M Cole; Roger H Reeves; Joan T Richtsmeier
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

9.  Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.

Authors:  Tomás Vacík; Michael Ort; Sona Gregorová; Petr Strnad; Radek Blatny; Nathalie Conte; Allan Bradley; Jan Bures; Jirí Forejt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

10.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.